Long-term heavy cannabis use: Implications for health education

Drugs: Education, Prevention and Policy

Volumn 11, Issue 4, 2004, Pages 299-313

  Coggans, Niall ^a   Dalgarno, Phil ^b   Johnson, Lindsay ^b   Shewan, David ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4444311809     PISSN: 09687637     EISSN: None     Source Type: Journal    
DOI: 10.1080/09687630410001687860     Document Type: Review

References (32)

1. ACMD (2002). The classification of cannabis under the Misuse of Drugs Act 1971. Advisory Committee on The Misuse of Drugs. London: Home Office.
2. ARSENEAULT, L., CANNON, M., POULTON, R., MURRAY, R., CASPI, A. & MOFFITT, T.E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212-1213.
3. BIERNACKI, P. & WALDORF, D. (1981). Snowball sampling: problems and techniques of chain referral sampling. Sociological Methods and Research, 10(2), 141-163.
4. BOVASSO, G.B. (2001). Cannabis use as a risk factor for depressive symptoms. American Journal of Psychiatry, 158, 2033-2037.
5. COGGANS, N., DALGARNO, P., JOHNSON, L. & SHEWAN, D. (2002). Long-term heavy cannabis use. London: Department of Health.
6. COHEN, P. & ARJAN, S. (1993). Ten years of cocaine. A follow-up study of 64 cocaine users in Amsterdam. Amsterdam: Department of Human Geography, University of Amsterdam.
7. CONDON, J. & SMITH, N. (2003). Prevalence of drug use: key findings from the 2002/03 British Crime Survey. London: Home Office Research, Development and Statistics Directorate.
8. FARRELL, M. (1999). Cannabis dependence and withdrawal. Addiction, 94, 1277-1278.
9. GOLDBERG, D.P., GATER, N., SARTOURIS, T.B., USTUN, M., PICCINELLI, O., GUREJE, C. & RUTTER, M. (1997). The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine, 27, 191-197.
10. GOSSOP, M., DARKE, S., GRIFFITHS, P., HANDO, J., POWIS, B., HALL, W. & STRANG, J. (1995). The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90(5), 607-614.
11. GRANT, I., GONZALES, R., CAREY, C.L., NATARAJAN, L. & WOLFSON, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. Journal of the International Neuropsychological Society, 9, 679-689.
12. HALL, W. & DEGENHARDT, L. (2000). Cannabis use and psychosis: a review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry, 34, 26-34.
13. HALL, W., SOLOWIJ, N. & LEMON, J. (1994). The health and psychological consequences of cannabis use. National Drug Strategy. Volume 25. Canberra, Australia: Australian Government Publishing Service.
14. HATHAWAY, A.D. (2003). Cannabis effects and dependency concerns in long-term frequent users: a missing piece of the public health puzzle. Addiction Research and Theory, 11(6), 441-458.
15. HOME OFFICE (2002). Updated drug strategy. London: Home Office.
16. IVERSON, L. (2003). Cannabis and the brain. Brain, 126, 1252-1270.
17. OPCS (1991). Classification of occupations. Office of Populations Censuses and Surveys. London: HMSO.
18. PATTON, G.C., COFFEY, C., CARLIN, J.B., DEGENHARDT, L., LYNSKEY, M. & HALL, W. (2002). Cannabis use and mental health in young people: cohort study. British Medical Journal, 325, 1195-1198.
19. PETO, R., DARBY, S., DEO, H., SILCOCKS, P., WHITLEY, E. & DOLL, R. (2000). Smoking, smoking cessation, and lung cancer in the UK since 1950; combination of national statistics with two case-control studies. British Medical Journal, 321, 323-329.
20. POPE, H.G. (2002). Cannabis, cognition and residual confounding. Journal of the American Medical Association, 287, 1172-1174.
21. POPE, H.G., GRUBER, A.J., HUDSON, J.I., HUESTIS, M.A. & YURGELUN-TODD, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58, 909-915.
22. REY, J.M. & TENNANT, C.C. (2002). Cannabis and mental health. British Medical Journal, 325, 1183-1184.
23. ROSENBERG, M.F. & ANTHONY, J.C. (2001). Early clinical manifestations of cannabis dependence in a community sample. Drug and Alcohol Dependence, 64, 123-131.
24. SHELDON, T. (2003). Review shows that cannabis use is a risk factor for schizophrenia. British Medical Journal, 327, 1070.
25. SIDNEY, S., BECK, J.E., TEKAWA, I.S., QUESENBURY, C.P. & FRIEDMAN, G.D. (1997). Marijuana use and mortality. American Journal of Public Health, 87(4), 585-590.
26. SOLOWIJ, N., STEPHENS, R.S., ROFFMAN, R.A., BABOR, T., KADDEN, R., MILLER, M., CHRISTIANSEN, K., MCREE, B. & VENDETTI, J. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American Medical Association, 287, 1123-1131.
27. SWIFT, W., COPELANP, J. & HALL, W. (1998). Choosing a diagnostic cut-off for cannabis dependence. Addiction, 93(11), 1681-1692.
28. SWIFT, W., HALL, W. & TEESSON, M. (2001). Cannabis use and dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing. Addiction, 96, 737-748.
29. TAYLOR, D.R., POULTON, R., MOFFITT, T.E., RAMANKUTTY, P. & SEARS, M.R. (2000). The respiratory effects of cannabis dependence in young adults. Addiction, 95(11), 1669-1677.
30. UNIVERSITIES SCOTLAND (2001). Students and social inclusion. At http://www.universities-scotland.ac.uk.
31. VAN OS, J., BACAK, M., HANSSEN, M., BIJL, R.V., DE GRAF, R. & VERDOUX, H. (2002). Cannabis use and psychosis: a longitudinal, population-based survey. American Journal of Epidemiology, 156, 319-327.
32. ZAMMIT, S., ALLEBECK, P., ANDREASSON, S., LUNDBERG, I. & LEWIS, G. (2002). Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal, 325, 1199-1203.